Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 19;25(1):47.
doi: 10.1186/s12931-024-02684-7.

Malignant pleural effusion: current understanding and therapeutic approach

Affiliations
Review

Malignant pleural effusion: current understanding and therapeutic approach

Francesca Gonnelli et al. Respir Res. .

Abstract

Malignant pleural effusion (MPE) is a common complication of thoracic and extrathoracic malignancies and is associated with high mortality and elevated costs to healthcare systems. Over the last decades the understanding of pathophysiology mechanisms, diagnostic techniques and optimal treatment intervention in MPE have been greatly advanced by recent high-quality research, leading to an ever less invasive diagnostic approach and more personalized management. Despite a number of management options, including talc pleurodesis, indwelling pleural catheters and combinations of the two, treatment for MPE remains symptom directed and centered around drainage strategy. In the next future, because of a better understanding of underlying tumor biology together with more sensitive molecular diagnostic techniques, it is likely that combined diagnostic and therapeutic procedures allowing near total outpatient management of MPE will become popular. This article provides a review of the current advances, new discoveries and future directions in the pathophysiology, diagnosis and management of MPE.

Keywords: Chest drain; Indwelling pleural catheter (IPC); Malignant pleural effusion (MPE); Oncology; Pleural; Pleurodesis; Thoracoscopy.

PubMed Disclaimer

Conflict of interest statement

FM serves as an Associate Editor on the Editorial Board of the Journal.The remaining authors have no conflict of interests to declare.

Figures

Fig. 1
Fig. 1
MPE pathogenetic mechanism
Fig. 2
Fig. 2
Management approach in MPE

References

    1. Aboudara M, Maldonado F. Update in the management of Pleural effusions. Med Clin North Am. 2019;103:475–85. doi: 10.1016/j.mcna.2018.12.007. - DOI - PubMed
    1. Villanueva A. Management of malignant pleural effusions. In: Ernst A, Herth FJ, editors. Principles and Practice of Interventional Pulmonology. New York: Springer; 2012. pp. 665–74.
    1. Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35:479–95. doi: 10.1183/09031936.00063109. - DOI - PubMed
    1. Roberts ME, Rahman NM, Maskell NA, et al. British thoracic Society Guideline for pleural disease. Thorax. 2023;78:1–42. doi: 10.1136/thorax-2022-219784. - DOI - PubMed
    1. Mummadi SR, Stoller JK, Lopez R, et al. Epidemiology of adult Pleural Disease in the United States. Chest. 2021;160:1534–51. doi: 10.1016/j.chest.2021.05.026. - DOI - PubMed